Royal Bank of Canada’s Compass Therapeutics CMPX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $393K | Buy |
151,142
+141,583
| +1,481% | +$368K | ﹤0.01% | 4317 |
|
|
2025
Q1 | $18K | Sell |
9,559
-5,784
| -38% | -$10.9K | ﹤0.01% | 5570 |
|
|
2024
Q4 | $23K | Buy |
15,343
+4,192
| +38% | +$6.28K | ﹤0.01% | 5560 |
|
|
2024
Q3 | $20K | Sell |
11,151
-21,507
| -66% | -$38.6K | ﹤0.01% | 5635 |
|
|
2024
Q2 | $33K | Buy |
32,658
+30,588
| +1,478% | +$30.9K | ﹤0.01% | 5451 |
|
|
2024
Q1 | $4K | Sell |
2,070
-27,018
| -93% | -$52.2K | ﹤0.01% | 6039 |
|
|
2023
Q4 | $45K | Buy |
29,088
+9,338
| +47% | +$14.4K | ﹤0.01% | 5508 |
|
|
2023
Q3 | $38K | Buy |
19,750
+7,000
| +55% | +$13.5K | ﹤0.01% | 5429 |
|
|
2023
Q2 | $41K | Buy |
12,750
+11,793
| +1,232% | +$37.9K | ﹤0.01% | 5417 |
|
|
2023
Q1 | $3K | Buy |
+957
| New | +$3K | ﹤0.01% | 6288 |
|
|
2022
Q4 | – | Sell |
-675
| Closed | -$2K | – | 6787 |
|
|
2022
Q3 | $2K | Buy |
675
+447
| +196% | +$1.32K | ﹤0.01% | 6501 |
|
|
2022
Q2 | $1K | Sell |
228
-555
| -71% | -$2.43K | ﹤0.01% | 6632 |
|
|
2022
Q1 | $1K | Buy |
+783
| New | +$1K | ﹤0.01% | 7093 |
|